Advertisement

Topics

Infect-ERA Company Profile

09:14 EST 12th December 2018 | BioPortfolio

Infect-ERA, a consortium funded under the Seventh Framework programme (FP7), is a continuation of the former ERA-NET PathoGenoMics. To date, it includes 14 partners from 11 countries and aims at coordinating research on infectious diseases, in support of high quality, cutting edge scientific research involving all aspects of human infection caused by bacteria, fungi, viruses and protozoa. Four Joint Transnational Calls are planned during the lifespan of Infect-ERA (2013-2016). Additional information is available at http://www.infect-era.eu/.


News Articles [75 Associated News Articles listed on BioPortfolio]

US Man Intentionally Contracted HIV To “Infect” Others, Gets 50 Years In Jail – NDTV

NDTVUS Man Intentionally Contracted HIV To "Infect" Others, Gets 50 Years In JailNDTVAn Arkansas man said he intentionally contracted HIV in an attempt to expose others to the virus. Stephen Koch, of ...

How MERS Coronavirus evolves to infect different species

New research shows how MERS-CoV can adapt to infect cells of a new species, which suggests that other coronaviruses might be able to do the same.

Study: How Hantaviruses Infect Lung Cells

NewsHantaviruses cause severe and sometimes fatal respiratory infections, but how they infect lung cells has been a mystery.

NIH-funded researchers identify how hantaviruses infect the lungs

(NIH/National Institute of Allergy and Infectious Diseases) A human protein associated with asthma is key to how hantaviruses infect the lungs and sometimes cause the life-threatening pulmonary condit...

Mechanical properties of viral DNA determine the course of infection

A new study reveals a previously unknown mechanism that governs whether viruses that infect bacteria will quickly kill their hosts or remain latent inside the cell. The discovery also may apply to vir...

NIH-funded study finds how hantaviruses infect the lungs

A human protein associated with asthma is key to how hantaviruses infect the lungs and sometimes cause a life-threatening pulmonary condition known as hantavirus pulmonary syndrome, according to resea...

Mechanical properties of viral DNA influence the course of infection, study finds

A new study reveals a previously unknown mechanism that governs whether viruses that infect bacteria will quickly kill their hosts or remain latent inside the cell. The discovery, reported in the jour...

Discovery: Mechanical properties of viral DNA determine the course of infection

(University of Illinois at Urbana-Champaign) A new study reveals a previously unknown mechanism that governs whether viruses that infect bacteria will quickly kill their hosts or remain latent inside ...

PubMed Articles [66 Associated PubMed Articles listed on BioPortfolio]

Domestic animals infected with Mycobacterium ulcerans-Implications for transmission to humans.

The environmental pathogen, Mycobacterium ulcerans (MU) can infect both humans and animals and cause Buruli ulcer (BU) disease. However, its mode(s) of transmission from the colonized environment to h...

"I will survive": A tale of bacteriophage-bacteria coevolution in the gut.

Viruses that infect bacteria, or bacteriophages, are among the most abundant entities in the gut microbiome. However, their role and the mechanisms by which they infect bacteria in the intestinal trac...

Efficient and reproducible experimental infections of rats with Blastocystis spp.

Although Blastocystis spp. infect probably more than 1 billion people worldwide, their clinical significance is still controversial and their pathophysiology remains poorly understood. In this study, ...

Are we letting neglect infect?

Paediatric dento-facial infections - a potential tool for identifying children at risk of neglect?

Influenza Virus.

This infographic briefly summarises the natural history, replication cycle, and pathogenesis of influenza viruses, the cause of seasonal influenza and of influenza pandemics. Influenza viruses infect ...

Clinical Trials [57 Associated Clinical Trials listed on BioPortfolio]

A Safety Study of Two Intratumoural Doses of Coxsackievirus Type A21 in Melanoma Patients

The purpose of the study is to determine the safety and tolerability of two doses of Coxsackievirus A21, administered 48 hours apart into a superficial melanoma tumour. Injected and non-i...

Plasmodium Resistance in A. Gambiae

The purpose of this study is to find new ways to control malaria by looking at mosquitoes infected with the disease. Knowledge of the genetics that affect the spread of malaria by mosquito...

The Role of Naive T-Cells in HIV Pathogenesis

While HIV mainly infects mature T-cells it can also infect newly produced (or naïve) T-cells. These infected naïve T cells may then act a viral reservoir even in patients with undetectab...

Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients

The purpose of this study is to see if it is safe and effective to give zintevir (AR177) to asymptomatic (no symptoms) HIV-infected patients. Zintevir belongs to a new class of anti-HIV d...

Relationship of Staphylococcal Colonization to Infection

Inpatients will be prospectively have nares screened and MRSA strains collected. All clinical MRSA strains of patients will also be prospectively collected. A sensitive strain discriminati...

Companies [7 Associated Companies listed on BioPortfolio]

Infect-ERA

Infect-ERA, a consortium funded under the Seventh Framework programme (FP7), is a continuation of the former ERA-NET PathoGenoMics. To date, it includes 14 partners from 11...

Calydon Incorporated

Calydon, a privately held company, was founded in 1994 with the specific goal of discovering and developing new drugs to treat prostrate cancer and related protrate disease. The company is focused on ...

Aeras Global TB Vaccine Foundation

ACE BioSciences is an emerging pharmaceutical company focused on developing novel, protein-based vaccines and antibodies to address infectious diseases caused by pathogens such as bacteria, fungi and ...

FluGen, Inc.

FluGen, Inc. is a privately held biotechnology company founded in 2005 and based in Madison, WI. The company has been developing novel influenza vaccine technology first invented ...

Welgen Incorporation

Welgen, Inc. was founded in 2002 to provide the fastest, most reliable technology available for the construction of recombinant adenoviruses and other research tools. We are currently located in a fac...

More Information about "Infect-ERA" on BioPortfolio

We have published hundreds of Infect-ERA news stories on BioPortfolio along with dozens of Infect-ERA Clinical Trials and PubMed Articles about Infect-ERA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Infect-ERA Companies in our database. You can also find out about relevant Infect-ERA Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...


Corporate Database Quicklinks



Searches Linking to this Company Record